Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Amortization - Intangibles: 2024-2025

Historic Amortization - Intangibles for Journey Medical (DERM) over the last 2 years, with Sep 2025 value amounting to $1.1 million.

  • Journey Medical's Amortization - Intangibles rose 30.71% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year change of. This contributed to the annual value of $3.4 million for FY2024, which is 9.11% down from last year.
  • According to the latest figures from Q3 2025, Journey Medical's Amortization - Intangibles is $1.1 million, which was down 0.00% from $1.1 million recorded in Q2 2025.
  • Journey Medical's 5-year Amortization - Intangibles high stood at $1.1 million for Q1 2025, and its period low was $814,000 during Q1 2024.
  • In the last 2 years, Journey Medical's Amortization - Intangibles had a median value of $981,000 in 2024 and averaged $945,143.
  • Data for Journey Medical's Amortization - Intangibles shows a peak YoY skyrocketed of 30.84% (in 2025) over the last 5 years.
  • Over the past 2 years, Journey Medical's Amortization - Intangibles (Quarterly) stood at $981,000 in 2024, then soared by 30.71% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.1 million for Q2 2025, and $1.1 million during Q1 2025.